Metraipolis › archive › dc_03bfd13f141b
Navigating Treatment Sequencing in Advanced HR+/HER2- Breast Cancer After CDK4/6 Inhibitors: Biomarker-Driven Strategies and Emerging Therapies — Europe PMC PMID:41226406
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41226406
- DOI
- 10.3390/ijms262110366
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T02:17:51.727Z
- SHA-256 of the archived text
fbbaed63831f1319f37dd2659bc48ed339111d969d7c5c0e5d279f6fa8e4767c- Stable URL of this page
https://metraipolis.com/documento/dc_03bfd13f141b
How to cite
Navigating Treatment Sequencing in Advanced HR+/HER2- Breast Cancer After CDK4/6 Inhibitors: Biomarker-Driven Strategies and Emerging Therapies — Europe PMC PMID:41226406 — Europe PMC (en), https://europepmc.org/article/MED/41226406 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_03bfd13f141b (Metraipolis archive dc_03bfd13f141b, sha256 fbbaed63831f1319f37dd2659bc48ed339111d969d7c5c0e5d279f6fa8e4767c)
BibTeX
@misc{dc03bfd13f141b,
title = {Navigating Treatment Sequencing in Advanced HR+/HER2- Breast Cancer After CDK4/6 Inhibitors: Biomarker-Driven Strategies and Emerging Therapies — Europe PMC PMID:41226406},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41226406},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_03bfd13f141b; sha256 fbbaed63831f1319f37dd2659bc48ed339111d969d7c5c0e5d279f6fa8e4767c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226406. Agents can read the archived copy with the MCP tool read_document.